The study will assess the safety, PK, PD, and preliminary efficacy of ABBV-CLS-484 as monotherapy and in combination with a PD-1 targeting agent or with a or a…

Advanced Solid Tumor Cancer

~Estimated

~$10 – $8,750

Calico Life Sciences LLCNCT04777994

Observational

The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer

Precision oncology has led to a growing population of adults with advanced cancer living increasingly longer lives in the face of profound uncertainty about th…

Advanced Solid Tumor CancerStage IV Cancer (Solid Tumors Only)Glioblastoma+2 more

~Estimated

~$10 – $6,250

University of Colorado, BoulderNCT07636200

Phase 1

Phase 1 Study of X-PACT (X-ray Psoralen Activated Cancer Therapy) for Intra-tumoral Injection of Superficial Tumors in Patients With Advanced Head and Neck Cancer, Breast Cancer, Soft Tissue Sarcoma or Melanoma

In this Phase I trial for subjects with advanced head \& neck cancer, breast cancer, soft tissue sarcoma or melanoma all subjects will receive open label X-PAC…

Advanced Solid Tumor Cancer

~Estimated

~$10 – $8,750

Immunolight, LLCNCT04389281